LONG-TERM EFFECTS OF ASPIRIN ON CARDIAC ALLOGRAFT VASCULOPATHY PROGRESSION AND ADVERSE OUTCOMES AFTER HEART TRANSPLANTATION

Rabea Asleh; Alexandros Briasoulis; Amir Lerman; Byron H. Smith; Camden L. Lopez; Naveen L. Pereira; Brooks S. Edwards; John M. Stulak; Walter K. Kremers; Alfredo L. Clavell; Richard C. Daly; Sudhir S. Kushwaha

doi:https://doi.org/10.1016/s0735-1097(20)31701-0

doi.org/10.1016/s0735-1097(20)31701-0

LONG-TERM EFFECTS OF ASPIRIN ON CARDIAC ALLOGRAFT VASCULOPATHY PROGRESSION AND ADVERSE OUTCOMES AFTER HEART TRANSPLANTATION

Rabea Asleh

21

,

Alexandros Briasoulis

32

,

..., Sudhir S. Kushwaha

42

Journal of the American College of Cardiology24.00

Volume: 75, Issue: 11, Pages: 1074 - 1074

Published: Mar 1, 2020

Abstract

Enhanced platelet reactivity may play a role in the development and progression of cardiac allograft vasculopathy (CAV). The use of anti-platelet agents following heart transplantation (HT) has been inconsistent and although aspirin is often a part of the medication regimen after HT,...

Paper Fields

Paper Details

Title

LONG-TERM EFFECTS OF ASPIRIN ON CARDIAC ALLOGRAFT VASCULOPATHY PROGRESSION AND ADVERSE OUTCOMES AFTER HEART TRANSPLANTATION

DOI

doi.org/10.1016/s0735-1097(20)31701-0

Published Date

Mar 1, 2020

Journal

Journal of the American College of Cardiology

Volume

75

Issue

11

Pages

1074 - 1074

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History